3-fluoro-4-[(1S)-1-[2-methyl-4-oxo-7-(trifluoromethyl)-3H-quinazolin-6-yl]propoxy]benzoic acid
C20H16F4N2O4 — CID 178097246
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-fluoro-4-[(1S)-1-[2-methyl-4-oxo-7-(trifluoromethyl)-3H-quinazolin-6-yl]propoxy]benzoic acid
3-fluoro-4-[(1S)-1-[2-methyl-4-oxo-7-(trifluoromethyl)-3H-quinazolin-6-yl]propoxy]benzoic acid (PubChem CID 178097246) has the molecular formula C20H16F4N2O4 and a molecular weight of 424.35 g/mol. Its IUPAC name is 3-fluoro-4-[(1S)-1-[2-methyl-4-oxo-7-(trifluoromethyl)-3H-quinazolin-6-yl]propoxy]benzoic acid.
Molecular Properties
| Compound Name | 3-fluoro-4-[(1S)-1-[2-methyl-4-oxo-7-(trifluoromethyl)-3H-quinazolin-6-yl]propoxy]benzoic acid |
|---|---|
| PubChem CID | 178097246 |
| Molecular Formula | C20H16F4N2O4 |
| Molecular Weight | 424.35 g/mol |
| Exact Mass | 424.10 |
| IUPAC Name | 3-fluoro-4-[(1S)-1-[2-methyl-4-oxo-7-(trifluoromethyl)-3H-quinazolin-6-yl]propoxy]benzoic acid |
| SMILES | CC[C@H](Oc1ccc(C(=O)O)cc1F)c1cc2c(=O)[nH]c(C)nc2cc1C(F)(F)F |
| InChI | InChI=1S/C20H16F4N2O4/c1-3-16(30-17-5-4-10(19(28)29)6-14(17)21)11-7-12-15(8-13(11)20(22,23)24)25-9(2)26-18(12)27/h4-8,16H,3H2,1-2H3,(H,28,29)(H,25,26,27)/t16-/m0/s1 |
| InChIKey | VYTLRSFGRMNGNW-INIZCTEOSA-N |
| XLogP | 4.62 |
| TPSA | 92.28 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.35 |
| LogP ≤ 5 | 4.62 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 178097246 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.